Qingyutang Pharmaceutical

Fuan Pharmaceutical Group Co., Ltd. was established on February 25, 2004, and on March 22, 2011, the company was successfully listed on the ChiNext Board of the Shenzhen Stock Exchange (stock code: 300194). The company owns 6 wholly-owned and controlled subsidiaries, namely: Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., mainly engaged in formulation production, Hubei Renmin Pharmaceutical Co., Ltd., and Chongqing Biological Products Co., Ltd., mainly engaged in pharmaceutical sales, Fuan Pharmaceutical Group Chongqing Libang Pharmaceutical Development Co., Ltd., engaged in pharmaceutical R&D, Guang'an Kaite Pharmaceutical Chemical Co., Ltd., engaged in the production of pharmaceutical intermediates, and Chongqing Fuan Pharmaceutical Group Kester Pharmaceutical Co., Ltd., a newly established controlled subsidiary in August 2013. At present, the company has formed a complete industrial chain from drug R&D to the production of pharmaceutical intermediates, APIs, and formulations, and then to product sales. Qingyutang Pharmaceutical Co., Ltd.* was first founded in March 1943 and has a history of more than 60 years. After the reform and opening up, with its good reputation, it was selected as a "China Time-honored Brand" enterprise by the Ministry of Internal Trade of the People's Republic of China on June 23, 1995. On April 24, 1996, Chongqing Yuzhong District Traditional Chinese Medicine Materials Company and Chongqing Huida Industrial Co., Ltd. jointly invested to establish Chongqing Qingyutang Pharmaceutical Co., Ltd. In 2003, the company carried out a shareholding system reform according to development needs and invested more than 50 million yuan to purchase about 30 mu of land in the High-tech Park of Renhe Town, Chongqing Northern New District, officially launching the GMP relocation and transformation project. In 2009, Fuan Pharmaceutical Group Co., Ltd. took control of Qingyutang Pharmaceutical Company. In April 2012, the company name was changed to Chongqing Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. In November 2013, due to the company's development, the name was changed to Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. The company now has 31 products with approval numbers (62 specifications), including 6 tablet varieties (6 specifications), 5 hard capsule varieties (6 specifications), 1 hard capsule (penicillin) variety (1 specification), 1 hard capsule (cephalosporin) variety (2 specifications), 3 small-volume injection varieties (10 specifications), 1 powder injection variety (3 specifications), 7 powder injection (cephalosporin) varieties (18 specifications), and 7 powder injection (penicillin) varieties (16 specifications). The company implements a general manager responsibility system under the leadership of the board of directors. It has an administrative department, finance department, quality assurance department, quality inspection department, equipment department, material control department, business department, planning and scheduling department, production workshops, etc. As of the end of September 2014, the company had 334 employees. Among them, 194 had a college degree or above; 56 were management personnel; and 164 were production department personnel. All personnel entering the company must undergo company-organized induction GMP training and various special trainings. The training content covers pharmaceutical regulations, GMP knowledge, production management, quality management, basic microbiology knowledge, and corresponding job knowledge, etc. Only after passing the assessment can they work independently. The company adheres to the principles of integrity and collaboration and the pursuit of excellence, and with a rigorous work style, strict quality assurance, and good team spirit, it lays a solid foundation for the company's long-term and stable development.